Skip to main content

Table 4 MOG35-55-most-downregulated genes (p < 0.005) that are not affected by CBD

From: Pathways and gene networks mediating the regulatory effects of cannabidiol, a nonpsychoactive cannabinoid, in autoimmune T cells

Symbol

Definition

Accession

MOG alone [fold]$

MOG+CBD [fold]$

CBD alone [fold]$

Il17re

Interleukin 17 receptor E, variant 2

NM_001034029.1

0.23

0.23

1.04

Sytl2

Synaptotagmin-like 2, variant 5

NM_001040088.1

0.25

0.27

1.03

Il17re

Interleukin 17 receptor E, variant 1

NM_145826.2

0.26

0.27

1.11

Tmem176a

Transmembrane protein 176A

NM_025326.2

0.28

0.30

1.07

Ian3

Immune associated nucleotide 3

NM_146167.2

0.29

0.23

0.94

Klrd1

Killer cell lectin-like receptor, subfamily D, member1

NM_010654.1

0.30

0.29

0.95

Klri2

Killer cell lectin-like receptor family I member 2

NM_177155.2

0.31

0.35

1.01

Sit1

Suppression inducing transmembrane adaptor 1

NM_019436.1

0.32

0.29

0.84

Il17rc

Interleukin 17 receptor C

NM_134159.2

0.33

0.36

0.95

Golph2

Type II Golgi transmembrane protein

NM_027307

0.35

0.35

0.94

  1. $The results are presented as fold change vs control (without MOG35-55 or CBD)